Open AccessThree‐field versus two‐field lymphadenectomy in transthoracic oesophagectomy for oesophageal squamous cell carcinoma: short‐term outcomes of a randomized clinical trial
Author(s) -
Li B.,
Hu H.,
Zhang Y.,
Zhang J.,
Miao L.,
Ma L.,
Luo X.,
Zhang Y.,
Ye T.,
Li H.,
Li Y.,
Shen L.,
Zhao K.,
Fan M.,
Zhu Z.,
Wang J.,
Xu J.,
Deng Y.,
Lu Q.,
Li H.,
Zhang Y.,
Pan Y.,
Liu S.,
Hu H.,
Shao L.,
Sun Y.,
Xiang J.,
Chen H.
Publication year - 2020
Publication title -
british journal of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.202
H-Index - 201
eISSN - 1365-2168
pISSN - 0007-1323
DOI - 10.1002/bjs.11497
Subject(s) - medicine , lymphadenectomy , randomized controlled trial , surgery , carcinoma , esophagectomy , lymph node , cancer , esophageal cancer
The benefit and harm of three-field lymphadenectomy for oesophageal cancer are still unknown. The aim of this study was to compare overall survival and morbidity and mortality between three- and two-field lymphadenectomy in patients with oesophageal squamous cell carcinoma.